Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2021 Mar 18;16:2247–2269. doi: 10.2147/IJN.S300594

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© 2021 Bian et al.

This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).

PMC Copyright notice

Inorganic nanomedicine. (A) Peptide–gold nanoparticle hybrids. (B) The nanoparticles effectively reduced lung injury and were effectively excreted at 26 h post-administration.

Notes: Reproduced with the permission from Xiong Y, Gao W, Xia F et al. Peptide-Gold Nanoparticle Hybrids as Promising Anti-Inflammatory Nanotherapeutics for Acute Lung Injury: In Vivo Efficacy, Biodistribution, and Clearance. Adv Healthc Mater. 2018;7(19):e1800510. © 2018 WILEY‐VCH Verlag GmbH & Co. KGaA, Weinheim.⁴¹